Table of Contents
• Neuropathic Pain overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Neuropathic Pain Market
• Global Epidemiology of Neuropathic Pain Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Neuropathic Pain Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Neuropathic Pain (2013-2023)
• Table 7: Neuropathic Pain Global Market (USD Millions), (2013-2015)
• Table 8: Neuropathic Pain Global Market (USD Millions), (2016-2023)
• Table 9: Neuropathic Pain US Market (USD Millions), (2013-2015)
• Table 10: Neuropathic Pain US Market (USD Millions), (2016-2023)
• Table 11: Neuropathic Pain Germany Market (USD Millions), (2013-2015)
• Table 12: Neuropathic Pain Germany Market (USD Millions), (2016-2023)
• Table 13: Neuropathic Pain United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Neuropathic Pain United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Neuropathic Pain France Market (USD Millions), (2013-2015)
• Table 16: Neuropathic Pain France Market (USD Millions), (2016-2023)
• Table 17: Neuropathic Pain Italy Market (USD Millions), (2013-2015)
• Table 18: Neuropathic Pain Italy Market (USD Millions), (2016-2023)
• Table 19: Neuropathic Pain Spain Market (USD Millions), (2013-2015)
• Table 20: Neuropathic Pain Spain Market (USD Millions), (2016-2023)
• Table 21: Neuropathic Pain Japan Market (USD Millions), (2013-2015)
• Table 22: Neuropathic Pain Japan Market (USD Millions), (2016-2023)
• Table 23: Neuropathic Pain ROW Market (USD Millions), (2013-2015)
• Table 24: Neuropathic Pain ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Neuropathic Pain Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Neuropathic Pain (2013-2023)
• Figure 3: Neuropathic Pain Global Market (USD Millions), (2013-2015)
• Figure 4: Neuropathic Pain Global Market (USD Millions), (2016-2023)
• Figure 5: Neuropathic Pain US Market (USD Millions), (2013-2015)
• Figure 6: Neuropathic Pain US Market (USD Millions), (2016-2023)
• Figure 7: Neuropathic Pain Germany Market (USD Millions), (2013-2015)
• Figure 8: Neuropathic Pain Germany Market (USD Millions), (2016-2023)
• Figure 9: Neuropathic Pain United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Neuropathic Pain United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Neuropathic Pain France Market (USD Millions), (2013-2015)
• Figure 12: Neuropathic Pain France Market (USD Millions), (2016-2023)
• Figure 13: Neuropathic Pain Italy Market (USD Millions), (2013-2015)
• Figure 14: Neuropathic Pain Italy Market (USD Millions), (2016-2023)
• Figure 15: Neuropathic Pain Spain Market (USD Millions), (2013-2015)
• Figure 16: Neuropathic Pain Spain Market (USD Millions), (2016-2023)
• Figure 17: Neuropathic Pain Japan Market (USD Millions), (2013-2015)
• Figure 18: Neuropathic Pain Japan Market (USD Millions), (2015-2023)
• Figure 19: Neuropathic Pain ROW Market (USD Millions), (2013-2015)
• Figure 20: Neuropathic Pain ROW Market (USD Millions), (2016-2023)
【掲載企業】
• Pfizer
• Eli Lilly
• Grünenthal
• Endo Health Solutions
• Janssen Pharmaceuticals
• Daiichi Sankyo
• Convergence Pharmaceuticals
【レポートのキーワード】
神経因性疼痛
【免責事項】
https://www.marketreport.jp/reports-disclaimer